Back to Search Start Over

Silver nano/microparticle toxicity in the shrimp Litopenaeus vannamei (Boone, 1931).

Authors :
Buitrago SAM
Colombo GM
Buitrago JR
Gomes RMM
de Sousa AC
Pedrosa VF
Romano LA
de Carvalho LM
Adolfo FR
Junior WW
Josende ME
Monserrat JM
Source :
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP [Comp Biochem Physiol C Toxicol Pharmacol] 2023 Feb; Vol. 264, pp. 109493. Date of Electronic Publication: 2022 Oct 24.
Publication Year :
2023

Abstract

The effects of silver nano/microparticles (AgP) on juvenile Litopenaeus vannamei shrimp were evaluated through several responses, aiming to use it as a prophylactic and therapeutic method. Shrimps (3.19 ± 0.13 g) were exposed to clear water for 3 h with increasing concentrations of nanosilver (0; 25; 100; and 400 μg/l). After 3 h of exposure, they were transferred to water without nanosilver for 30 days (recovery). The weight gain and weekly growth were not affected by AgNP. Total antioxidant capacity (ACAP) increased in the hepatopancreas (exposure period) and gills (recovery) in shrimp exposed to AgNP. In muscle, ACAP was induced in shrimp exposed to 100 μg/l AgNP (exposure). In the gills, there was an increase in TBARS in shrimp exposed to 100 μg/l AgNP (recovery). In the concentration of protein-associated sulfhydryl groups (P-SH), a decrease was observed in the hepatopancreas (recovery) in the 100 μg/l AgNP treatment. In chromaticity parameters, an increase in reddish tones was observed in shrimp exposed to 100 μg/l AgNP (recovery). An increase in granular hemocytes was verified in shrimp exposed to 25 and 400 μg/l AgNP during exposure. Tissues analyzed histologically showed normal patterns without apoptosis or necrosis processes, and after 30 d of recovery, only in one muscle sample of shrimp exposed to μg/l of AgNP was silver detected. It is concluded that a prophylactic action of short duration (3 h) mostly did not affected the welfare of shrimp L. vannamei and can be considered its use as a therapeutic strategy.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2022. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1532-0456
Volume :
264
Database :
MEDLINE
Journal :
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP
Publication Type :
Academic Journal
Accession number :
36302473
Full Text :
https://doi.org/10.1016/j.cbpc.2022.109493